{"id":369198,"date":"2021-02-10T00:17:19","date_gmt":"2021-02-10T08:17:19","guid":{"rendered":"https:\/\/nai500.com\/blog\/2021\/02\/bristol-myers-announce-new-late-stage-data-for-opdivo-cabometyx-combo-in-kidney-cancer-merck-antiviral-molnupiravir-effective-in-preventing-covid-19-in-lung-tissue\/"},"modified":"2021-02-10T00:18:07","modified_gmt":"2021-02-10T08:18:07","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e7%99%be%e6%97%b6%e7%be%8e%e6%96%bd%e8%b4%b5%e5%ae%9d%e5%ae%a3%e5%b8%83-opdivo-cabometyx-%e7%bb%84%e5%90%88%e6%b2%bb%e7%96%97%e8%82%be%e7%99%8c","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2021\/02\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e7%99%be%e6%97%b6%e7%be%8e%e6%96%bd%e8%b4%b5%e5%ae%9d%e5%ae%a3%e5%b8%83-opdivo-cabometyx-%e7%bb%84%e5%90%88%e6%b2%bb%e7%96%97%e8%82%be%e7%99%8c\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u5ba3\u5e03Opdivo\/Cabometyx\u7ec4\u5408\u6cbb\u7597\u80be\u764c\u7684\u6700\u65b0\u540e\u671f\u6570\u636e\uff1b\u9ed8\u514b\u6297\u75c5\u6bd2molnupiravir\u6709\u6548\u9884\u9632\u80ba\u7ec4\u7ec7\u4e2d\u7684COVID-19"},"content":{"rendered":"<h2><strong>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d<\/strong>\u5ba3\u5e03Opdivo\/Cabometyx\u7ec4\u5408\u6cbb\u7597\u80be\u764c\u7684\u6700\u65b0\u540e\u671f\u6570\u636e<\/h2>\n<p><strong>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d<\/strong> (NYSE: <a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=bmy\">BMY<\/a>)\u548cExelixis, Inc.(NASDAQ:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=exel\">EXEL<\/a>)<a href=\"https:\/\/seekingalpha.com\/pr\/18183798-opdivo-nivolumab-in-combination-cabometyx-cabozantinib-shows-sustained-survival-and-response?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u62ab\u9732\u4e86<\/a>Opdivo\/Cabometyx\u7ec4\u5408\u5728\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u80be\u7ec6\u80de\u764c\u7684\u5173\u952e\u60273\u671f\u8bd5\u9a8c\u4e2d\u7684<u>\u65b0\u6570\u636e<\/u>\u3002<\/p>\n<p>\u8be5\u8bd5\u9a8c\u7531\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u548cOno Pharmaceutical (<u>OTC:OPHLF<\/u>)\u8d5e\u52a9\uff0cExelixis\u3001Ipsen (<u>OTCPK:IPSEF<\/u>)\u548c\u6b66\u7530\u5236\u836f(NYSE:<u>TAK<\/u>)\u5171\u540c\u51fa\u8d44\uff0c\u8bc4\u4f30\u5bf9\u8be5\u9002\u5e94\u75c7\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002<\/p>\n<p>\u4e3b\u8981\u7ec8\u70b9\u662f\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08&#8221;PFS&#8221;\uff09\uff0c\u6b21\u8981\u7ec8\u70b9\u5305\u62ec\u603b\u751f\u5b58\u671f\uff08&#8221;OS&#8221;\uff09\u548c\u5ba2\u89c2\u53cd\u5e94\u7387\uff08&#8221;ORR&#8221;\uff09\u3002<\/p>\n<p>\u7ecf\u8fc7\u4e24\u5e74\uff0823.5\u4e2a\u6708\uff09\u7684\u4e2d\u4f4d\u968f\u8bbf\uff0c\u6ca1\u6709\u53d1\u73b0\u65b0\u7684\u5b89\u5168\u4fe1\u53f7\u3002<\/p>\n<p>Exelixis\u9996\u5e2d\u533b\u7597\u5b98Gisela Schwab\u8bf4\uff1a&#8221;\u8fd9\u4e9b\u6765\u81eaCheckMate -9ER\u7684\u65b0\u53d1\u73b0\u548c\u6700\u8fd1FDA\u6279\u51c6\u7684\u8054\u5408\u65b9\u6848\u662f\u975e\u5e38\u4ee4\u4eba\u9f13\u821e\u7684\uff0c\u6211\u4eec\u8fdb\u4e00\u6b65\u63a2\u7d22CABOMETYX\u4e0e\u514d\u75ab\u7597\u6cd5\u8054\u5408\u7684\u6f5c\u529b\uff0c\u4ee5\u5e2e\u52a9\u66f4\u591a\u96be\u4ee5\u6cbb\u7597\u7684\u80bf\u7624\u7c7b\u578b\u7684\u60a3\u8005&#8221;\u3002<\/p>\n<p>\u4e0a\u4e2a\u6708\uff0cFDA\u6279\u51c6Opdivo\/ Cabometyx\u7528\u4e8e<u>\u665a\u671f\u80be\u7ec6\u80de\u764c<\/u>\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u3002<\/p>\n<h2><strong>\u9ed8\u514b\u516c\u53f8\u6297\u75c5\u6bd2<\/strong><strong>molnupiravir<\/strong><strong>\u6709\u6548\u9884\u9632\u80ba\u7ec4\u7ec7\u4e2d<\/strong><strong>COVID-19<\/strong><strong>\u7684\u53d1\u751f<\/strong><\/h2>\n<p>\u5317\u5361\u7f57\u6765\u7eb3\u5927\u5b66\u7684\u7814\u7a76\u4eba\u5458\u8868\u793a\uff0c\u9ed8\u514b\uff08NYSE:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=mrk\">MRK<\/a>\uff09\u548cRidgeback Biotherapeutics\u516c\u53f8\u6b63\u5728\u5f00\u53d1\u7684molnupiravir\u53ef\u4ee5\u6709\u6548\u9884\u9632\u548c\u6cbb\u7597COVID-19\u3002<\/p>\n<p>\u53d1\u8868\u5728\u300a<a href=\"https:\/\/www.nature.com\/articles\/s41586-021-03312-w?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u81ea\u7136\u300b<\/a>\u6742\u5fd7\u4e0a\u7684\u7814\u7a76\u53d1\u73b0\uff0cmolnupiravir\uff08\u53c8\u79f0EIDD-2801\uff09\u80fd\u963b\u6b62SARS-CoV-2\u7684\u590d\u5236\uff0c\u9632\u6b62\u4eba\u4f53\u7ec6\u80de\u611f\u67d3\u3002<\/p>\n<p>\u9ad8\u7ea7\u4f5c\u8005J.Victor Garcia\u535a\u58eb\u8bf4\uff1a&#8221;\u6211\u4eec\u53d1\u73b0\uff0cEIDD-2801\u4ec5\u5728\u6cbb\u7597\u4e24\u5929\u540e\u5c31\u5bf9\u75c5\u6bd2\u590d\u5236\u4ea7\u751f\u4e86\u663e\u8457\u7684\u6548\u679c&#8211;\u5f53\u611f\u67d3\u540e24\u5c0f\u65f6\u5f00\u59cb\u6cbb\u7597\u65f6\uff0c\u4eba\u7c7b\u80ba\u7ec4\u7ec7\u4e2d\u7684\u611f\u67d3\u6027\u9897\u7c92\u6570\u91cf\u5927\u5e45\u51cf\u5c11\u4e8625000\u591a\u500d&#8221;\u3002<\/p>\n<p>molnupiravir\u76ee\u524d\u6b63\u5728\u8fdb\u884c2\u671f\u548c3\u671f\u7684\u8bd5\u9a8c\u3002<\/p>\n<p>\u9ed8\u514b\u80a1\u4ef7\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\u4e0b\u8dcc0.5%\uff0c\u81f374.69\u7f8e\u5143\u3002<\/p>\n<h2><strong>\u5927\u9ebb\u80a1\u5927\u6da8<\/strong><\/h2>\n<p>\u5728Tilray(NASDAQ:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=tlry\">TLRY<\/a>)<a href=\"https:\/\/seekingalpha.com\/news\/3659858-tilray-shares-up-10-on-distribution-deal-with-grow-pharma-in-uk?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u7b7e\u7f72\u5728\u82f1\u56fd\u5206\u9500\u533b\u7528\u5927\u9ebb\u4ea7\u54c1<\/a>\u7684\u534f\u8bae\u4ee5\u53caCanopy Growth(NYSE:<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=cgc\">CGC<\/a>)<a href=\"https:\/\/seekingalpha.com\/news\/3659909-canopy-growth-fiscal-q3-sales-beats-forecast-posts-top-line-growth-of-23?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u7b2c\u4e09\u8d22\u5b63\u8425\u6536\u8d85\u9884\u671f\u7684\u60c5\u51b5\u4e0b\uff0c<\/a>\u5927\u9ebb\u80a1\u5728\u76d8\u524d\u4ea4\u6613\u4e2d\u4e0a\u6da8\u3002<\/p>\n<p>\u76f8\u5173\u80a1\u7968\uff1aAurora Cannabis(NYSE:ACB)+5.4%\uff0cHexo(NYSE:HEXO)+4.8%\uff0cAphria(NASDAQ:APHA)+12.8%\uff0cCronos Group(NASDAQ:CRON)+2.8%\uff0cOrganiGram Holdings(NASDAQ:OGI)+10%\u3002<\/p>\n<p>\u5927\u76d8\u6307\u6570\u4e5f\u5927\u5e45\u4e0a\u6da8\uff0c\u5927\u9ebbETF ETFMG Alternative Harvest(NYSEARCA:MJ)\u4e0a\u6da8\u7ea66%\uff0c\u800cGlobal X Cannabis ETF(NASDAQ:POTX)\u5927\u6da88%\u3002Spinnaker Cannabis ETF(NYSEARCA:THCX)\u4e0a\u6da88.2%\u3002<\/p>\n<p>\u5728Jazz Pharmaceuticals\u5ba3\u5e03\u8ba1\u5212\u4ee5$72\u4ebf\u6536\u8d2d\u533b\u7528\u5927\u9ebb\u516c\u53f8GW Pharma\u540e\uff0c\u523a\u6fc0\u4e86\u5927\u9ebb\u677f\u5757\u7684\u4e0a\u6da8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u5ba3\u5e03Opdivo\/Cabometyx\u7ec4\u5408\u6cbb\u7597\u80be\u764c\u7684\u6700\u65b0\u540e\u671f\u6570\u636e \u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d (NYSE: BMY [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":369195,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,925,459],"class_list":["post-369198","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/369198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=369198"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/369198\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/369195"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=369198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=369198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=369198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}